NeuBase Therapeutics, Inc. Quarterly report pursuant to Section 13 or 15(d)

Equipment

3 Months Ended

Dec. 31, 2021

4. Equipment

The Company’s equipment consisted of the following:


	As of December 31,		As of September 30,
	2021		2021
Laboratory equipment	$	2,909,472	$	2,737,390
Office equipment		259,978		259,978
Leasehold improvements		10,128		—
Total		3,179,578		2,997,368
Accumulated depreciation		(714,935)		(533,486)
Property, plant and equipment, net	$	2,464,643	$	2,463,882

Depreciation expense for the three months ended December 31, 2021 and 2020 was approximately $0.2 million and $0.1 million, respectively.